Status:

COMPLETED

Stability and Balance in Locomotion Through Exercise

Lead Sponsor:

University of Erlangen-Nürnberg

Collaborating Sponsors:

German Foundation for Neurology

Department of Molecular Neurology, Faculty of Medicine, University Erlangen-Nürnberg

Conditions:

Parkinson's Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

Persons with Morbus Parkinson commonly develop gait and balance disorders leading to dependence, loss of mobility and a high risk of falling. This study investigates the effectiveness of a sensorimot...

Eligibility Criteria

Inclusion

  • Parkinson's disease stage 1-3 Hoehn and Yahr
  • United Parkinson Disease Rating Scale (UPDRS) 'gait' or 'postural stability' subscore of 1 or more
  • Ability to stand unaided and walk without an assistive device
  • Stable medication during the study period

Exclusion

  • On-off and wearing-off phenomena
  • Unstable medical or psychiatric illness
  • Clinically relevant cardiovascular or orthopaedic disease
  • Severe polyneuropathy
  • Cognitive impairment

Key Trial Info

Start Date :

June 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2016

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT01856244

Start Date

June 1 2013

End Date

June 1 2016

Last Update

October 5 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Institute of Sport Science and Sport, Gebbertstr. 123b

Erlangen, Germany, 91058